Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Nat Commun. 2021 Jul 16;12(1):4355. doi: 10.1038/s41467-021-24570-2.
Mucosal-associated Invariant T (MAIT) cells are recognized for their antibacterial functions. The protective capacity of MAIT cells has been demonstrated in murine models of local infection, including in the lungs. Here we show that during systemic infection of mice with Francisella tularensis live vaccine strain results in evident MAIT cell expansion in the liver, lungs, kidney and spleen and peripheral blood. The responding MAIT cells manifest a polarised Th1-like MAIT-1 phenotype, including transcription factor and cytokine profile, and confer a critical role in controlling bacterial load. Post resolution of the primary infection, the expanded MAIT cells form stable memory-like MAIT-1 cell populations, suggesting a basis for vaccination. Indeed, a systemic vaccination with synthetic antigen 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil in combination with CpG adjuvant similarly boosts MAIT cells, and results in enhanced protection against both systemic and local infections with different bacteria. Our study highlights the potential utility of targeting MAIT cells to combat a range of bacterial pathogens.
黏膜相关不变 T(MAIT)细胞因其抗菌功能而被认可。MAIT 细胞的保护能力已在局部感染的小鼠模型中得到证实,包括肺部。在这里,我们表明,在感染弗氏柠檬酸杆菌活疫苗株的系统性感染期间,MAIT 细胞在肝脏、肺部、肾脏和脾脏以及外周血中明显扩增。反应性 MAIT 细胞表现出极化的 Th1 样 MAIT-1 表型,包括转录因子和细胞因子谱,并在控制细菌负荷方面发挥关键作用。在原发性感染解决后,扩增的 MAIT 细胞形成稳定的记忆样 MAIT-1 细胞群体,这表明了疫苗接种的基础。事实上,用合成抗原 5-(2-氧代丙基氨基)-6-D-核糖基氨基尿嘧啶与 CpG 佐剂联合进行全身疫苗接种同样会增强 MAIT 细胞,从而增强对不同细菌的全身和局部感染的保护作用。我们的研究强调了靶向 MAIT 细胞来对抗一系列细菌病原体的潜在效用。